Justices Back Mayo Clinic Argument on Patents
nytimes.com
nytimes.com
I'm not even happy, simply relieved. It's taken years and years to begin affirming what should you obvious: you shouldn't be allowed to patent nature. It boggles the mind how it came to this, how we arrived at the notion that someone could patent nature. Software patents are bad enough, whereas patents on biological aspects are much more dangerous. Take gene patents--these patents set biology back years every time someone receives one.
This assumption is based on the demonstrably wrong assumption that the ONLY motivating factor driving medical development is predatory rent-seeking of the most odious kind. Were it not for this, the thinking goes, people would all just suffer and die in silence.
People whose lives are seriously impacted by any condition have a serious motivation to pool resources in an effort to find a cure. To date, the transaction costs have been prohibitive, giving the predatory motivation more power. But there's no reason why the Kickstarter model can't be adapted to this problem - especially when researchers are bolstered by fundamental research done at the NIH. An additional source of funding could come from health insurance companies, who back promising projects because it lowers their costs.
We need to demolish the idea that patents are the one and only pathway to medical advance. In some ways, this is more important that going after software patents, since any time patent reform comes up, drug patents get wheeled out as the prime example of "good" patents. They're deployed like a rhetorical third rail, and a useful way to shut down any conversation about patent reform in general.
sighs
I guess unless the company was in bankruptcy and the judge ruled you couldn't challenge their patents ala Kodak. Then having granted stupid patents in the first place would not have been such a good idea Mr. Holder.
For instance, the FDA had to use a bullshit process to get clinical research done on colchicine for gout. There is also some research that vitamin D deficiency is causing many unnecessary deaths, but no ongoing clinical trials. The status quo needs to get fixed.
The price went from $0.09/pill to $4.85/pill overnight.
Oh, and an easy citation is wikipedia: http://en.wikipedia.org/wiki/Colchicine http://en.wikipedia.org/wiki/Colchicine#Marketing_exclusivit...
From the article:
"That year, the FDA started their "Unapproved Drugs Initiative", through which they sought more rigorous testing of efficacy and safety of colchicine and other unapproved drugs on the market.[26] In exchange for paying for the costly testing, the FDA gave URL Pharma three years of market exclusivity for its Colcrys brand,[27] under the Hatch-Waxman Act"
It will get done the same way a lot of research that has no immediate monetary value (but still is quite valuable to humanity) gets done. i.e. Astronomy, Anthropology, theoretical physics, etc, etc
Big pharma is just trying to scare you.